Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR-IDA: Ferric Carboxymaltose in IDA with Impaired Renal Function
NCT00981045Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- Aug 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Aug 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00981045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981045.